NSUN5 and glioma: Epigenetic inactivation of NSUN5 is a hallmark of long-term survival in patients with glioma, but paradoxically, this adaptive regulation may also allow cancer cells to survive in the face of destructive stress conditions (chemotherapeutic agents) to avoid death and ultimately reduce patients’ therapeutic sensitivity to TMZ (Janin et al., 2019).